ストックスクリーナーアプリを入手
150.36
0.02%
-0.60
アフターアワーズ：
149.32
-1.04
-0.69%
前日終値:
$149.76
開ける：
$148.87
24時間の取引高:
853.68K
Relative Volume:
0.82
時価総額：
$9.98B
収益：
$13.64B
当期純損益:
$1.05B
株価収益率:
15.74
EPS:
9.555
ネットキャッシュフロー:
$1.31B
1週間 パフォーマンス:
-0.65%
1か月 パフォーマンス:
-0.66%
6か月 パフォーマンス:
+15.04%
1年 パフォーマンス:
+0.49%
1日の値動き範囲:
$148.87
$152.49
1週間の範囲:
$147.76
$152.49
52週間の値動き範囲:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
149.33 | 10.01B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
493.88 | 111.71B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
200.42 | 17.84B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
21.63 | 12.35B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
200.16 | 11.77B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
185.72 | 11.44B | 17.36B | 1.51B | 849.25M | 23.15 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
DaVita Stock: Is DVA Outperforming the Health Care Sector? - Barchart
DaVita Inc Stock (ISIN: US23804L1035) Gains on Value-Based Care Progress Amid Institutional Selling - AD HOC NEWS
DaVita reports progress in value-based kidney care programs - Investing.com
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement - PR Newswire
Chart Watch: Will DaVita Inc stock benefit from M A2026 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Zacks Investment Research
DaVita getting closer to key technical benchmark - MSN
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita tops chart as the only large-cap healthcare services name rated strong buy - MSN
DaVita (DVA) Backs R1 Therapeutics with Major Investment - GuruFocus
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease - GlobeNewswire Inc.
Zacks.com featured highlights include Strategic Education, Seanergy Maritime Holdings, DaVita and FirstEnergy - Yahoo Finance
Delta Global Management LP Buys New Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc Stock (ISIN: US23804L1035) Faces Headwinds Amid Dialysis Demand Shifts and Regulatory Scr - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. Trade Ideas — LS:897914 - TradingView
DaVita Stock Sits at $151 With Analysts Pointing to a $190 High Target - TIKR.com
DaVita Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
DaVita Inc. $DVA Shares Acquired by Doma Perpetual Capital Management LLC - MarketBeat
Aquatic Capital Management Boosts Stake in DaVita - National Today
Aquatic Capital Management LLC Acquires 40,333 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Berkshire Hathaway Inc - MarketBeat
Is DaVita (DVA) Pricing Reflect Its Strong Multi‑Year Share Performance And Cash Flow Outlook - simplywall.st
DVA (DaVita) Graham Number : $N/A (As of Dec. 2025) - GuruFocus
DaVita (DVA) and Jazz Pharmaceuticals (JAZZ) Lead with Strong Bu - GuruFocus
DaVita Inc Stock (ISIN: US23804L1035) Gains Momentum on Institutional Buying and Strong Guidance - AD HOC NEWS
Jim Cramer on DaVita: "Haven’t seen that stock do that well in this long" - MSN
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Te Ahumairangi Investment Management Ltd Has $9.10 Million Position in DaVita Inc. $DVA - MarketBeat
DaVita, Inc. Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
A Look At DaVita (DVA) Valuation As Analyst Concerns Clash With Bullish Ratings - simplywall.st
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DAVITA INC (NYSE:DVA) Emerges as a Technical Breakout Candidate - ChartMill
Ohio Hospital Defeats DaVita's Dialysis Discrimination Suit - Law360
Are Investors Undervaluing DaVita (DVA) Right Now? - Yahoo Finance
DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range - MSN
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship - CSRwire
Dimensional Fund Advisors LP Grows Holdings in DaVita Inc. $DVA - MarketBeat
WINTON GROUP Ltd Invests $5.76 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. (DVA) Receives Top Rating Amid Healthcare Sector Pre - GuruFocus
How DaVita’s Buybacks-Driven Earnings Outlook Despite Falling Volumes Will Impact DaVita (DVA) Investors - simplywall.st
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy (DVA:NYSE) - Seeking Alpha
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract - MSN
40,785 Shares in DaVita Inc. $DVA Bought by Munich Reinsurance Co Stock Corp in Munich - MarketBeat
DaVita Rethinks Kidney Care As Volumes Decline And Elara Stake Grows - Yahoo Finance
DaVita Inc. (NYSE:DVA) Q4 2025 earnings call transcript - MSN
Reassessing DaVita (DVA) Valuation After Strong Q4 2025 Earnings Beat And Upgraded Guidance - Yahoo Finance
Neuberger Berman Group LLC Has $61.50 Million Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Tuesday when compared to competitors - MSN
DaVita Confronts Volume Pressure While Expanding Integrated Kidney Care Model - simplywall.st
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
Davita Inc (DVA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| ACKERMAN JOEL | CFO and Treasuer |
Feb 06 '26 |
Option Exercise |
108.93 |
44,065 |
4,800,000 |
185,705 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Jan 29 '26 |
Sale |
120.56 |
1,658,480 |
199,939,881 |
30,100,585 |
| HEARTY JAMES O | Chief Compliance Officer |
Dec 04 '25 |
Option Exercise |
108.93 |
5,875 |
639,964 |
31,913 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Oct 27 '25 |
Sale |
135.36 |
401,514 |
54,347,249 |
31,759,065 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Jul 31 '25 |
Sale |
140.61 |
1,635,962 |
230,024,764 |
32,160,579 |
| HEARTY JAMES O | Chief Compliance Officer |
Jul 23 '25 |
Sale |
150.00 |
2,351 |
352,650 |
26,038 |
1.71%
大文字化:
|
ボリューム (24 時間):